Walgreens Boots Alliance, Inc. (WBA) Holdings Decreased by Advisor Group Inc.

Advisor Group Inc. cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 59,471 shares of the pharmacy operator’s stock after selling 239 shares during the period. Advisor Group Inc.’s holdings in Walgreens Boots Alliance were worth $4,645,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Nordea Investment Management AB increased its position in shares of Walgreens Boots Alliance by 10.2% during the second quarter. Nordea Investment Management AB now owns 10,085,836 shares of the pharmacy operator’s stock valued at $789,822,000 after acquiring an additional 931,508 shares during the last quarter. Glenview Trust Co increased its position in shares of Walgreens Boots Alliance by 1.4% during the second quarter. Glenview Trust Co now owns 155,689 shares of the pharmacy operator’s stock valued at $12,192,000 after acquiring an additional 2,141 shares during the last quarter. Cibc World Markets Corp increased its position in shares of Walgreens Boots Alliance by 76.7% during the second quarter. Cibc World Markets Corp now owns 661,034 shares of the pharmacy operator’s stock valued at $51,766,000 after acquiring an additional 286,959 shares during the last quarter. Suntrust Banks Inc. increased its position in shares of Walgreens Boots Alliance by 0.7% during the second quarter. Suntrust Banks Inc. now owns 89,658 shares of the pharmacy operator’s stock valued at $7,019,000 after acquiring an additional 580 shares during the last quarter. Finally, Horizon Investments LLC acquired a new stake in shares of Walgreens Boots Alliance during the second quarter valued at about $668,000. Institutional investors and hedge funds own 63.58% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at $71.25 on Friday. The firm has a market cap of $71,930.37, a P/E ratio of 13.97, a PEG ratio of 1.27 and a beta of 1.20. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance, Inc. has a 12-month low of $63.82 and a 12-month high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The company’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.07 EPS. research analysts expect that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.25%. Walgreens Boots Alliance’s dividend payout ratio is presently 42.33%.

Walgreens Boots Alliance declared that its Board of Directors has approved a share repurchase plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://transcriptdaily.com/2017/11/19/walgreens-boots-alliance-inc-wba-holdings-decreased-by-advisor-group-inc.html.

A number of research analysts recently weighed in on WBA shares. Pivotal Research dropped their price objective on shares of Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating for the company in a report on Tuesday, October 24th. Loop Capital started coverage on shares of Walgreens Boots Alliance in a report on Thursday, August 24th. They issued a “buy” rating and a $95.00 price objective for the company. Needham & Company LLC restated a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, October 12th. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. Finally, Royal Bank Of Canada restated a “buy” rating and issued a $88.00 price objective on shares of Walgreens Boots Alliance in a report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $87.63.

In related news, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The stock was acquired at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 13.50% of the stock is currently owned by insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply